Doxribtimine

Doxribtimine

SCHEMBL12286396

Cc1cn([C@@H]2CC(O)[C@@H](CO)O2)c(=O)[nH]c1=O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

P

The experimentally established mechanism targets of Doxribtimine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ TK1 P04183 4/20 0.73
▸ LMNA P02545 3/20 0.73
▸ SMN1; SMN2 Q16637 2/20 0.73
▸ TK2 O00142 1/20 0.71
▸ ALOX12 P18054 1/20 0.69
▸ ADRA1A P35348 1/20 0.69
▸ ALB P02768 1/20 0.67
▸ PKM P14618 1/20 0.67
▸ BLM P54132 1/20 0.67
▸ PMP22 Q01453 1/20 0.67
▸ TSHR P16473 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Doxribtimine SCHEMBL778861 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL4201980 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL542736 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL16189745 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL2922181 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL7882259 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL3437225 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL23486 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL21078835 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL3437224 1.00 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725479-B2 5′-end derivatives IONIS PHARMACEUTICALS, INC. (US) 2017-08-08 — — US disclosed
US-9725479-B2 5′-end derivatives IONIS PHARMACEUTICALS, INC. (US) 2017-08-08 — — US disclosed
WO-2011133871-A2 5'-END DERIVATIVES ALNYLAM PHARMACEUTICALS, INC. (US) 2011-10-27 — — WO disclosed
Send feedback